Adam Cotton

Company: Novartis AG

Job title: Associate

Seminars:

Panel Discussion: : Examining Partner & Investor Perspectives to Fulfil the Future Opportunities of Covalent Drug Discovery & Development 10:15 am

What is investible when considering the covalency programs/platforms? What do investors look for when investing in covalent pipelines? Is a particular target or indication of interest? How to secure interest from collaboration partners and discussing how assets are considered versus platformsRead more

day: Conference Day Two